Designing novel multifunctional nanosystems to improve intracellular delivery
Designing novel multifunctional nanosystems to improve intracellular delivery
批准号:
RGPIN-2022-04398
负责人:
Gadde, Suresh
金额:
$2.11万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
人们对将纳米技术应用于医学的兴趣与日俱增,纳米医学是由于其在药物输送、诊断和成像方面的吸引人的特征。基于纳米技术的药物输送平台(纳米颗粒,NPs)通常在1-100 nm的范围内,能够将数千种治疗性和/或成像剂包裹在其纳米结构中,并将它们直接输送到疾病部位,从而增强其治疗效果并将有害毒性降至最低。尽管有巨大的热情和投资,该领域还没有充分发挥其潜力,因为只有17种纳米药物在欧洲和北美被批准用于临床。为了最大限度地发挥纳米技术在医疗保健中的应用潜力,需要解决几个问题,如优化纳米粒子的生物物理化学性质,获得对纳米生物相互作用的基本了解,以及改善治疗药物的细胞内释放。我们研究计划的长期愿景是建立一个基本框架,用于合理设计和开发针对特定部位的NPs,克服各种生物障碍到达所需部位,确定最佳NP剂量范围以实现最大效果,并将纳米材料本身造成的不良影响降至最低。为此,我的研究计划主要围绕两个相互关联的主题:设计和合成先进的多功能NP平台,以改进各种药物的细胞内递送;以及探索它们在体外和体内环境下与血液、组织、细胞和细胞内成分的相互作用。拟议研究计划的短期目标是在NPs的细胞内运输和有效载荷传递的背景下,详细了解氧化还原响应型NPs与细胞内成分的纳米生物相互作用。我们的目标是:1)开发用于核苷酸递送的新型氧化还原响应型纳米粒子。2)研究NP与内体-溶酶体成分的相互作用对生物环境中细胞内转运和递送的影响。长期目标是将从这些研究中获得的知识纳入反馈循环,以开发下一代核动力源。我的研究成果将为合理设计有效的纳米药物输送系统提供指导,从而推动纳米医学研究领域的发展。最重要的是,在这项研究计划中培训的高素质人员将学习化学、工程和生物方面的各种实验和分析技能。此外,他们还将受益于强大的跨学科环境,并获得宝贵的研究经验,为他们在工业和学术界的职业生涯做好准备。
英文摘要
The growing interest in applying nanotechnology to medicine, nanomedicine, is due to its appealing features in drug delivery, diagnosis, and imaging. Nanotechnology-based drug delivery platforms (nanoparticles, NPs) are typically in 1-100 nm range, capable of encapsulating thousands of therapeutic and/or imaging agents inside their nanostructures and delivering them directly to the disease sites, enhancing their therapeutic effects and minimizing unwanted toxicities. Despite significant enthusiasm and investment, the field has not yet reached its full potential, as only ~17 nanomedicines have been approved for clinical use in Europe and North America. Several issues, such as optimizing the biophysiochemical properties of NPs, gaining the fundamental understanding of nano-bio interactions, and improving the intracellular delivery of therapeutic agents, need to be addressed to maximize the potential of nanotechnology applications in healthcare. The long-term vision of our research program is to develop a fundamental framework for rationally designing and developing NPs for site-specific delivery, overcoming a variety of biological barriers to reach desired sites, identifying optimal NP dose ranges to achieve maximum effect, and minimizing adverse effects induced by the nanomaterials themselves. To this end, my research program is centred around two main interconnected themes: the design and synthesis of advanced multifunctional NP platforms for improved intracellular delivery of a variety of agents; and the exploration of their interactions with blood, tissue, cellular and intracellular components in vitro and in vivo settings. The short-term objective of the proposed research program is to gain a detailed understanding of nano-bio interactions of redox-responsive NPs with intracellular components in the context of NPs' intracellular trafficking and payload delivery. Our aims are 1) Develop novel redox-responsive NPs for nucleotides delivery. 2) Study the impact of NP's interactions with endosomal-lysosomal components on intracellular trafficking and delivery in biological settings. The long-term goal is to incorporate the knowledge gained from these studies into a feedback loop to develop next-generation NPs. The outcome of my research program will provide guidelines for rationally designing potent nanoparticle-based drug delivery systems and thus advancing the nanomedicine research field. Most importantly, highly qualified personnel trained in this research program will learn various experimental and analytical skills in chemistry, engineering, and biology. Additionally, they will also benefit from a robust interdisciplinary environment and gain valuable research experience equipping them for careers in both industry and academia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing novel multifunctional nanosystems to improve intracellular delivery
-
批准号:DGECR-2022-00065
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2022
-
负责人:Gadde, Suresh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
-
批准号:32402377
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:戴恬美
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位: